Search alternatives:
decrease » increase (Expand Search)
doses » does (Expand Search), dose (Expand Search)
Showing 1 - 20 results of 233 for search '(( significant treatment decrease ) OR ( significant differences doses ))', query time: 0.10s Refine Results
  1. 1

    The Effect of Different Doses of Intravenous Dexmedetomidine on the Properties of Subarachnoid Blockade: A Systematic Review and Meta-Analysis by Mohammad K Al Nobani (16561248)

    Published 2020
    “…We analyzed the duration of sensory and motor blockade and the related adverse effects in relation to different doses of IV dexmedetomidine.</p><p><b>Results:</b> Intravenous dexmedetomidine, with loading dose of 1 mcg/kg, prolonged the sensory blockade duration of spinal anaesthesia by a mean difference of 49.6 min, P<0.001, and motor blockade duration by a mean difference of 44.7 min, P<0.001, while a loading dose of 0.5 mcg/kg prolonged the sensory blockade by a mean difference of 43.06 min, P<0.001, and motor blockade duration by a mean difference of 29.09 min, P<0.001. …”
  2. 2

    Indomethacin as a Rescue Therapy for Patent Ductus Arteriosus in Extremely Premature Infants after Failed Ibuprofen Treatment by Amal Sabouni (17046236)

    Published 2023
    “…We aim to find the success rates of indomethacin treatment for hsPDA following unsuccessful ibuprofen treatment. …”
  3. 3

    Effect of age and sex on warfarin dosing by Khoury, Ghada

    Published 2014
    “…The primary outcome assessed was warfarin total weekly dose (TWD). Results There was a statistically significant difference in the TWD among the ages (P<0.01); older patients required lower doses. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  4. 4

    Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants by Saad, Aline

    Published 2006
    “…By bringing similarities and differences among these agents and their potential interactions to clinicians’ attention, they can appreciate and apply these findings in a individualized patient approach rather than follow only the one-size-fits-all dosing recommendations suggested in many tertiary references. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  5. 5

    Investigating the Effect of Patient-Related Factors on Computed Tomography Radiation Dose Using Regression and Correlation Analysis by AlShurbaji, Mohammad

    Published 2024
    “…Investigating the relationships between the different dose indices, statistically significant relationships were found between all dose indices. …”
    Get full text
    article
  6. 6

    Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study by Salam Ibrahim Abou Safrah (21264303)

    Published 2025
    “…</p><h3>Conclusion</h3><p dir="ltr">There is no significant difference in the incidence of bleeding or VTE between the reduced dose and the standard dose of enoxaparin for VTE prophylaxis in underweight adult patients. …”
  7. 7
  8. 8
  9. 9

    Kefir exhibits anti‑proliferative and pro‑apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion by Khoury, Nathalie

    Published 2014
    “…Furthermore, results from time‑lapse motility movies, wound‑healing, and invasion assays showed no effect on the motility of colorectal as well as breast (MCF‑7 and MB‑MDA‑231) cancer cells upon kefir treatment. Our data suggest that kefir is able to inhibit the proliferation and induce apoptosis in HT‑29 and Caco‑2 CRC cells, yet it does not exhibit a significant effect on the motility and invasion of these cells in vitro.…”
    Get full text
    Get full text
    Get full text
    article
  10. 10

    A comparative single-dose bioequivalence study of two Glibenclamide brands among healthy volunteers. (c2000) by Tannous, Elias Fouad

    Published 2000
    “…Furthermore, the difference between area under serum concentration-time curve (AUC) for the two products ( 390.86 ± 152.61 and 360.7 ± 160.21 ng hr Iml for A and B, respectively) was not statistically significant, with P > 0.05. …”
    Get full text
    Get full text
    masterThesis
  11. 11

    Inland Treatment of the Brine Generated from Reverse Osmosis Advanced Membrane Wastewater Treatment Plant Using Epuvalisation System by Qurie, Mohannad

    Published 2013
    “…Plant growth parameters (plant height, fresh and dry weight) showed no significant difference between fresh water and brine treatments. …”
    Get full text
    article
  12. 12

    A comparative single-dose bioequivalence study of two enteric coated Aspirin brands among healthy volunteers. (c2001) by Zeitoun, Abeer Abbas

    Published 2001
    “…Moreover, there was no statistically significant difference with respect to peak serum concentration (The Cmax values for Aspicot® (23,66 ± 16,26 ~g / mL) and Aspirin Protect® (21.73 ± 11.33 ug / mL) or to corresponding peaks time (the Tmax values ( 4,92 ± 2.35 hours and 4,58 ± 1,5 1 hours for Aspicot® and Aspirin Protect® respectively), Furthermore, the difference between area under the serum concentration time curve for the two products (the AUC for Aspicot® (66,20 ± 42,90 ug / mL) and Aspirin Protect® (64,79 ± 38,02 ug / mL) was not statistically significant, with P > 0,05. …”
    Get full text
    Get full text
    masterThesis
  13. 13

    Thymoquinone from Nigella sativa seeds promotes the antitumor activity of noncytotoxic doses of topotecan in human colorectal cancer cells in vitro by Khalife, Rana

    Published 2016
    “…The reduction in proliferation was significantly dose- and time-dependent. After determining the best combination (40 µM thymoquinone and 0.6 µM topotecan), cell proteins were extracted after treatment, and the expression levels of B-cell lymphoma 2 and of its associated X protein, proteins p53 and p21, and caspase-9, caspase-3, and caspase-8 were studied by Western blot. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  14. 14

    Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: A randomized controlled trial by Jabbour, Jana

    Published 2022
    “…Similarly, no significant differences were noted in the proportion of patients with SO at study entry (1.8% in LDG vs 1.6% HDG; p = 0.99) and at 12 months (3.7% in LDG vs. 0.9% HDG; p = 0.18) across arms. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  15. 15

    Assessment of four dose calculation algorithms using IAEA-TECDOC-1583 with medium dependency correction factor (K<sub>med</sub>) application by Aram Rostami (22045274)

    Published 2024
    “…</p><h3>Conclusions</h3><p dir="ltr">This study highlights the significant impact of applying K<sub>med</sub> on dose differences between measurement and calculation during the dose audit process.…”
  16. 16

    Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation by Ghazi, Nicola G.

    Published 2008
    “…No significant side effects were observed. Conclusion: These short-term data suggest that bevacizumab is a viable treatment option for RAP in AMD. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  17. 17

    Dosage, time, and polytherapy dependent effects of different levetiracetam regimens on cognitive function by Jon Davis Perkins (17885747)

    Published 2023
    “…</p><h3>Significance</h3><p dir="ltr">When taken in small doses, for brief periods as monotherapy, levetiracetam minimally influences cognition.…”
  18. 18

    Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK) by Majdoleen Alalawneh (13961580)

    Published 2024
    “…Rivaroxaban's exposure was similar between the obese and non‐obese subjects, and there were no significant differences in other pharmacokinetic parameters between the two groups. …”
  19. 19
  20. 20

    Metformin treatment inhibits motility and invasion of glioblastoma cancer cells by Al Hassan, Marwa

    Published 2018
    “…The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article